AEBi
Therapeutic Peptides for Personalized Cancer Treatment
Startup Pre-Funding Health Tech & Life Sciences Est. 2000
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
3
1-10 employees
Confidence
96/100
News
3
articles
Patents
1
About
Accelerated Evolution Biotechnologies (AEBi) is a development-stage biopharmaceutical company engaged in the discovery and development of therapeutic peptides. The company has developed an IP-protected combinatorial biology screening platform technology that can be used to find binders to known targets and select the best functional molecules among them. AEBis platform is extremely flexible, harnessing combinatorial biology to discover new and better lead compounds to disease targets. AEBi was incorporated at the Weizmann Institutes ITEK technological incubator in Nes-Tziona, Israel. The company has a collaboration agreement with Israeli biopharmaceutical company Proteologics.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
BiologicalsMolecules
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B
Tags
drug-developmentdrug-discoverybiopharmaceuticalpharma-companiespatent-pendingscreeningpharmaceuticalspersonalized-medicinecancer
News (3)
Mar 21, 2019 · www.irishtimes.com
growth-positive
Israeli cancer treatment could be something special
InvestmentPartnersCustomers
Jan 30, 2019 · www.timesofisrael.com
growth-negative
'Cancer cure' doubted as Israeli team claims it can't afford to publish findings
InvestmentExpand
Jan 30, 2019 · www.forbes.com
growth-negative
An Israeli Company Claims That They Will Have A Cure For Cancer In A Year. Don't Believe Them.
CustomersInvestment
Details
Product Stage
R&D
Employees
1-10
Exact Count
1
District
Center District
Founded
2000
Registrar
512970054
Crunchbase
aebi-accelerated-evolution-biotechnologies
Locations
Einstein St 13, Ness Ziona, Israel
Links
Website
LinkedIn
Admin
Last Update
Sep 21, 2024
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
video or image, funding rounds, markets
Team (3)
Dan Aridor
Chairman of the Board
Ilan Morad, PhD
Founder & CEO
Founder
Hanan Itzhaki, PH.D
CSO
Internal
Created by
Yanina Wainscheinker (yanina.wain@gmail.com)
Created
2015-02-12T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)